Abstracts tagged "Hip"

Abstract Number: 2970 • 2014 ACR/ARHP Annual Meeting
Psoriatic Arthritis is Associated with Heterotopic Ossification after Total Hip Arthroplasty
Mario Cedillo¹, Arielle Fein², Susan M. Goodman³, Rebecca Zhu⁴, Mark P. Figgie⁵, Michael Alexiades⁶, Jayme C. Burket⁷ and Lisa A. Mandl³, ¹Weill Cornell Medical College, New York, NY, ²Hospital for Special Surgery, New York, NY, ³Rheumatology, Hospital for Special Surgery, New York, NY, ⁴Clinical Research, Hospital for Special Surgery, New York, NY, ⁵Orthopedics, Hospital for Special Surgery, New York, NY, ⁶Orthopaedics, Hospital for Special Surgery, New York, NY, ⁷Healthcare Research Institute, Hospital for Special Surgery, New York, NY
Background/Purpose: Heterotopic ossification (HO), the pathologic deposition of ectopic bone in soft tissues, is a feared complication of total hip arthroplasty (THA). HO is strongly…
Abstract Number: 2941 • 2014 ACR/ARHP Annual Meeting
Physical Function Is Independently Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project
Rebecca J. Cleveland¹, Todd Schwartz¹, Jordan B. Renner², Joanne M. Jordan³ and Leigh F. Callahan⁴, ¹Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²University of North Carolina Department of Radiology, Chapel Hill, NC, ³University of North Carolina Dept of Epidemiology, Chapel Hill, NC, ⁴Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC
Background/Purpose Declining physical function (PF) is a common consequence of osteoarthritis (OA), and poor PF is associated with death. It is possible that the resulting…
Abstract Number: 2437 • 2014 ACR/ARHP Annual Meeting
Why Doesn’t Participation in Activity Increase Following Hip or Knee Replacement?
Aileen Davis¹, Viji Venkataramanan¹, Jessica Bytautas², Rose Wong¹, Lisa Carlesso¹, Anthony Perruccio³ and Fiona Webster², ¹Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ²Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada, ³Toronto Western Hospital, University Health Network, Toronto, ON, Canada
Background/Purpose Activity is critical for healthy aging. Our prior work demonstrated that despite improved pain and function, people did not increase their participation in activity…
Abstract Number: 2249 • 2014 ACR/ARHP Annual Meeting
Criteria for Clinically Important Worsening in Knee and Hip Osteoarthritis
Elien A.M. Mahler¹, Alfons A. den Broeder², Vincent J.J.F. Busch³, Johannes W.J. Bijlsma⁴ and Els van den Ende¹, ¹Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ²Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ³Orthopedics, Sint Maartenskliniek, Nijmegen, Netherlands, ⁴Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands
Background/Purpose Clinically important worsening in OA has not been well defined. Validated worsening criteria are important for research but also clinical practice to make informed…
Abstract Number: 1854 • 2014 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosus Patients Have Increased Risk of Short Term Adverse Events after Total Hip Arthroplasty
Jordan Roberts¹, Lisa A. Mandl², Edwin Su³, David J. Mayman⁴, Mark P. Figgie⁴, Arielle Fein⁵, Yuo-Yu Lee⁵, Ummara Shah⁶ and Susan M. Goodman², ¹Weill Cornell Medical College, New York, NY, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Orthopedic Surgery, Hospital for Special Surgery, New York, NY, ⁴Orthopedics, Hospital for Special Surgery, New York, NY, ⁵Hospital for Special Surgery, New York, NY, ⁶Division of Rheumatology, New York University School of Medicine, NYC, NY
Background/Purpose: Total Hip Arthroplasty (THA) is the most frequent orthopedic procedure performed in lupus (SLE) patients. Whether SLE patients have higher rates of complications after…
Abstract Number: 1802 • 2014 ACR/ARHP Annual Meeting
Are Outcomes after Total Knee Arthroplasty Worsening over Time? a Time-Trends Study of Activity Limitation and Pain Outcomes
Jasvinder A. Singh¹ and David Lewallen², ¹University of Alabama and VA Medical Center, Birmingham, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester, MN
Background/Purpose: To examine whether function and pain outcomes of patients undergoing primary total knee arthroplasty (TKA) are changing over time.Methods: The Mayo Clinic Total Joint…
Abstract Number: 1043 • 2014 ACR/ARHP Annual Meeting
Identification of Putative Biomarkers and Molecular Mechanisms Associated with Adverse Tissue Reactions to Metal-on-Metal and Modular Neck Hip Implants
Ed Purdue¹, Gabrielle Wilner², Kritti Kolatat², Geoffrey H. Westrich³, Friedrich Boettner⁴, Seth Jerabek⁴ and Steven R. Goldring⁵, ¹535 East 70th Street, Hospital for Special Surgery, New York, NY, ²Research, Hospital for Special Surgery, New York, NY, ³Orthopedics, Hospital for Special Surgery, New York, NY, ⁴Orthopaedics, Hospital for Special Surgery, New York, NY, ⁵Hospital for Special Surgery, New York, NY
Background/Purpose Total hip replacement (THR) is a highly successful treatment for degenerative arthritis, alleviating pain and restoring joint function in the vast majority of patients.…
Abstract Number: 219 • 2014 ACR/ARHP Annual Meeting
DXA Body Composition, Sarcopenia and Knee and Hip Osteoarthritis: Results from the Khoala Cohort
Clémence Jeanmaire¹, Isabelle Chary-Valkenaere¹, Damien Loeuille², Lorraine Bernard³ and Anne-Christine Rat,⁴, ¹Rheumatology, CHU Nancy, Vandoeuvre Les Nancy, France, ²Rheumatology, CHU Brabois, Vandoeuvre les Nancy, France, ³CHU Nancy, Pôle S2R, Epidémiologie et Evaluation Cliniques, INSERM, CIC-EC, CIE6, Vandoeuvre Les Nancy, France, ⁴Université de Lorraine, Nancy, F-54000, France; Inserm, , CIC-EC, CIC 1433, Nancy, F-54000, France; CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, F-54000, France; CHU de Nancy, Rheumatology department, Nancy, France
Background/Purpose Obesity is a well known risk factor for the development and progression of knee osteoarthritis (OA), and to a lesser extent of hip OA.…
Abstract Number: 199 • 2014 ACR/ARHP Annual Meeting
Increasing Complexity of Patients Undergoing Primary Total Hip Arthroplasty in the U.S
Jasvinder A. Singh¹ and David Lewallen², ¹University of Alabama and VA Medical Center, Birmingham, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester, MN
Background/Purpose: To examine the time-trends in key demographic and clinical characteristics of patients undergoing primary total hip arthroplasty (THA).Methods: We used the data from the…
Abstract Number: 196 • 2014 ACR/ARHP Annual Meeting
Dependence on Walking Aids Is Associated with Pain and Mobility Limitation after Total Hip Arthroplasty
Jasvinder A. Singh¹ and David Lewallen², ¹University of Alabama and VA Medical Center, Birmingham, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester, MN
Background/Purpose: To assess the association of dependence on walking aids with pain and function outcomes after total hip arthroplasty (THA).Methods: We used the Mayo Clinic…
Abstract Number: 266 • 2013 ACR/ARHP Annual Meeting
Cardiovascular Disease In Osteoarthritis: Hip Versus Knee and The Influence Of Multiple Symptomatic Joint Involvement
Anthony V. Perruccio¹, Rita A. Kandel² and Aileen M. Davis³, ¹Toronto Western Hospital, Toronto Western Research Institute, and University of Toronto, Toronto, ON, Canada, ²Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, ³Health Care and Outcomes Research, Toronto Western Research Institute; Departments of Rehabilitation Science and Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
Background/Purpose: The strength of association between obesity and osteoarthritis (OA) is reported to vary by joint (e.g. stronger association with knee than hip). As well,…
Abstract Number: 244 • 2013 ACR/ARHP Annual Meeting
Association Between Serum Adipokine Levels and Extent Of Symptomatic Joint Involvement In Hip and Knee Osteoarthritis
Anthony V. Perruccio¹, Vinod Chandran², Nizar N. Mahomed³ and Rajiv Gandhi⁴, ¹Toronto Western Hospital, Toronto Western Research Institute, and University of Toronto, Toronto, ON, Canada, ²Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Orthopaedic Surgery, University Health Network and University of Toronto, Toronto, ON, Canada, ⁴University Health Network, Arthritis Program, Toronto, ON, Canada
Background/Purpose: Osteoarthritis (OA) has not traditionally been considered a systemic joint disease. However, a growing body of evidence suggests that OA cannot solely be accounted…
Abstract Number: 236 • 2013 ACR/ARHP Annual Meeting
Hip Bone Marrow Lesions In Asymptomatic and Osteoarthritic Adults: Prevalence, Risk Factors and Significance
L Dawson¹, Yuanyuan Wang¹, Anita Wluka², Kim Bennell³, Andrew Teichtahl⁴ and Flavia Cicuttini², ¹Monash University, Melbourne, Australia, ²Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, ³University of Melbourne, Melbourne, Australia, ⁴Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Background/Purpose: Bone marrow lesions (BMLs) at the knee have an important role in the pathogenesis of osteoarthritis (OA), being associated with increased pain, accelerated cartilage…
Abstract Number: 95 • 2013 ACR/ARHP Annual Meeting
Hip Osteoarthritis and Risk Of All Cause and Disease-Specific Mortality Among Older Women: A Population-Based Cohort Study
Kamil E. Barbour¹, Li-Yung Lui², Charles G. Helmick³, Kristina A. Theis⁴, Michael C. Nevitt⁵, Nancy E. Lane⁶, Louise Murphy¹, Jennifer M. Hootman⁷, Marc C. Hochberg⁸ and Jane A. Cauley⁹, ¹Centers for Disease Control and Prevention, Atlanta, GA, ²California Pacific Medical Center, San Francisco, CA, San Francisco, CA, ³National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ⁴Athritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ⁵Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, ⁶Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, ⁷Division of Population Health, Centers for Disease Control and Prevention, Kennesaw, GA, ⁸Medicine, University of Maryland School of Medicine, Baltimore, MD, ⁹Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: The morbidity of osteoarthritis (OA) is well documented; however few comprehensive studies have examined the effect of OA on mortality. Methods: We used data…
Abstract Number: 2855 • 2013 ACR/ARHP Annual Meeting
Association Of Back Pain With Functional Limitations In Patients With Knee and Hip Osteoarthritis
Adam P. Goode¹, Hayden B. Bosworth², Cynthia Coffman², Amy Jeffreys³, Eugene Z. Oddone³, William S. Yancy Jr.⁴ and Kelli D. Allen³, ¹Community and Family Medicine, Duke University, Durham, NC, ²Health Services Research, Durham VA Medical Center and Duke University Medical Center, Durham, NC, ³Health Services Research, Duke and Durham VA Medical Center, Durham, NC, ⁴Health Services Research, Durham VA Medical Center, Durham, NC
Background/Purpose: Back pain, most commonly occurring in the lower back, is a prevalent condition and common reason for both decreased function and quality of life.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.